| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 12/26/2007 | EP1870104A1 Composition for the relief of joint pain |
| 12/26/2007 | EP1869165A1 Isolation of adult multipotential cells by tissue non-specific alkaline phosphatase |
| 12/26/2007 | EP1869031A1 Thiadiazole substituted coumarin derivatives and their use as leukotriene biosynthesis inhibitor |
| 12/26/2007 | EP1869001A1 Substituted tetrahydroisochinolines as mmp inhibitors, related production method and use as medicine |
| 12/26/2007 | EP1868994A1 Sulfonylpyrroles as histone deacetylase inhibitors |
| 12/26/2007 | EP1868633A2 Compositions and methods for the inhibition of dishevelled proteins |
| 12/26/2007 | EP1868627A2 Use of calcitonin as combined treatment therapy for the management of inflammatory disease conditions |
| 12/26/2007 | EP1868617A1 Combination of a silicon containing component and a hormone |
| 12/26/2007 | EP1868611A2 Novel compounds |
| 12/26/2007 | EP1868584A1 Dosage forms of risedronate |
| 12/26/2007 | EP1868437A1 Method of treating or preventing bone deterioration or osteoporosis |
| 12/26/2007 | EP1235596B1 Use of lytic toxins and toxin conjugates |
| 12/26/2007 | CN101094680A Regimens for intra-articular viscosupplementation |
| 12/26/2007 | CN101092442A Steroid compounds having contraceptive and anti-osteoporosis activity |
| 12/26/2007 | CN101092400A 黄嘌呤氧化酶抑制剂 Xanthine oxidase inhibitors |
| 12/26/2007 | CN101091795A Prevention and treatment of synucleinopathic disease |
| 12/26/2007 | CN101091758A Chinese traditional medicine for treating rheumatoid disease and osteoarthritis and preparation method |
| 12/26/2007 | CN101091737A Compound preparation of Chinese traditional medicine for treating osteoarthrosis, and preparation method |
| 12/26/2007 | CN101091720A Health food with efficacy for preventing osteoporosis and preparation method |
| 12/26/2007 | CN101091707A Medicinal usage of kuhseng extractive |
| 12/26/2007 | CN101091703A Renin inhibitor-containing synergetic compositions designated for treatment of cardiovascular disease |
| 12/26/2007 | CN101091692A EDNA skin support factors |
| 12/26/2007 | CN100357293C Diazinopyrimidines |
| 12/26/2007 | CN100357281C Bicyclic compounds, process for their preparation and pharmaceutical composition containing them |
| 12/26/2007 | CN100357276C Quinoline and quinoxaline compounds as PDGF-R and/or LCD tyrosine kinase inhibitors |
| 12/26/2007 | CN100357275C N-pyrazinyl-phenylsulphonamides and their use in the treatment of chemokine mediated diseases |
| 12/26/2007 | CN100357244C Aspirin-triggered lipid mediators |
| 12/26/2007 | CN100356979C Integrin expression inhibitors |
| 12/26/2007 | CN100356939C Medicine for treating osteoporosis and its production method |
| 12/26/2007 | CN100356936C Medicine oil for relaxing joints and its prepn |
| 12/26/2007 | CN100356930C External-use powder for treating swelling anducler and actue-chronic osteomyelitis |
| 12/26/2007 | CN100356928C Use of red yeast in preparing anti-inflammatory medicine |
| 12/26/2007 | CN100356914C Method for preparing soybean isoflavone tablet |
| 12/25/2007 | US7312353 Cathespin cysteine protease inhibitors |
| 12/25/2007 | US7312344 Dimeric isoflavones |
| 12/25/2007 | US7312328 Antiinflammatory agents; autoimmune disease; rheumatic diseases; multiple sclerosis; respiratory system disorders |
| 12/25/2007 | US7312321 Antibody to human enzymes of the metalloprotease family |
| 12/25/2007 | US7312304 Somatostatin agonists |
| 12/25/2007 | US7312234 Chemokine receptor binding heterocyclic compounds |
| 12/25/2007 | US7312232 Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof |
| 12/25/2007 | US7312230 Carboxylic acid derivatives as IP antagonists |
| 12/25/2007 | US7312227 Autoimmune diseases; Alzheimer's disease; Parkinson's disease; bone disorders; liver disorders; rheumatic disease; amythrophiic lateral sclerosis |
| 12/25/2007 | US7312224 Pyrimidine derivatives |
| 12/25/2007 | US7312211 Cathepsin S, K, F, L and B reversible inhibitory amidino and guanidino peptidyl compounds useful for treating autoimmune diseases, rheumatoid arthritis, multiple sclerosis, asthma and osteoporosis |
| 12/25/2007 | US7312209 An immunosuppressants for treating allograft rejection, transplant rejection, psoriasis, and rheumatoid arthritis, a 9,10-dihydro-9-oxo-acridine-3-yl- derivatives |
| 12/25/2007 | US7312203 1H-8-oxa-1-aza-dibenzo[e,h]azulene; dual inhibitors of tumour necrosis factor(alpha) and interleukin 1; antiinflammatory, analgesics |
| 12/25/2007 | US7312193 Calcium phosphopeptide complexes |
| 12/25/2007 | US7311919 Agents for treating osteoporosis and inhibiting osteoclast formation |
| 12/25/2007 | US7311905 Embryonic-like stem cells derived from post-partum mammalian placenta, and uses and methods of treatment using said cells |
| 12/21/2007 | WO2007145306A1 Element having long blood-circulating time which is degradable selectively in tumor tissue |
| 12/21/2007 | WO2007144381A1 Composition for the relief of joint pain |
| 12/21/2007 | WO2007112913A3 Benzimidazole derivatives |
| 12/21/2007 | WO2007064620A3 Compositions comprising a combination of ccr5 and cxcr4 antagonists |
| 12/21/2007 | CA2654722A1 Thiadiazole compounds and methods of use thereof |
| 12/20/2007 | US20070293587 Combating sinus, throat, and blood infections with xylitol delivered in the mouth |
| 12/20/2007 | US20070293578 N1-(1-cyanocyclopropyl)-N2-(1-{4'-[2,2-difluoro-1-hydroxyethyl]biphenyl-4-yl}-2,2,2-trifluorethyl)-4-fluoro-L-leucinamide; antiarthritic agent; osteoporosis and other bone loss disorders |
| 12/20/2007 | US20070293560 Compounds and compositions |
| 12/20/2007 | US20070293555 4-methoxy-benzoic acid 1-imidazol-1-yl methyl-2-(4-fluorophenoxy)-ethyl ester; N-[(1-imidazol-1-yl methyl)-2-phenoxy-ethyl]-4-iodo-benzamide; cancer, inflammation, septic shock, infertility, preterm labor, pain, or an ischemia |
| 12/20/2007 | US20070293529 Tetrasubstituted ureas as modulators of 11-beta hydroxyl steroid dehydrogenase type 1 |
| 12/20/2007 | US20070293528 non-steroidal partial activators and/or tissue-specific activators or inhibtors for androgen receptors, used for treating acne, alopecia, hirsutism, prostatic hyperplasia or prostate cancer |
| 12/20/2007 | US20070293512 2-[4-(4-Chlorophenylthio)-3-nitrophenyl]-4-mercaptothiazolo[5,4-d]pyrimidine; hyperuricemia; gout |
| 12/20/2007 | US20070293498 used for the treatment of cachexia and other weight loss disorders, such as those resulting from cancer, HIV, old age and anorexia nervosa |
| 12/20/2007 | US20070293496 Nitrogen containing heterocyclic compounds and medicines containing the same |
| 12/20/2007 | US20070293477 Novel Compounds |
| 12/20/2007 | US20070293474 Combination of a DPP IV inhibitor and a cardiovascular compound |
| 12/20/2007 | US20070293425 Mutein of a Bone Morphogenetic Protein and Use Thereof |
| 12/20/2007 | US20070293418 Therapeutic amino acid sequences for use in treatment and prevention of viral, infectious, cancerous, diabetic, incontinent, hypertensive and nervous system disorders |
| 12/20/2007 | US20070292966 Assessment of Skeletal Growth Using Measurements of Nt-Cnp Peptides |
| 12/20/2007 | US20070292533 Copper lowering treatment of autoimmune diseases |
| 12/20/2007 | US20070292515 Solid dosage form containing a taste masked active agent |
| 12/20/2007 | US20070292514 Bioengineered Intervertebral Discs and Methods for Their Preparation |
| 12/20/2007 | US20070292456 Formulations Containing an Immune Response Modifier |
| 12/20/2007 | US20070292444 Peptides for treatment and diagnosis of bone diseases |
| 12/20/2007 | US20070292442 Using cation exchange to separate host cell protein (HCP) form preferential antibody on chromatographic column |
| 12/19/2007 | EP1867337A1 Medicinal composition for treating/preventing motor organ disease |
| 12/19/2007 | EP1865954A2 Methods for avoiding edema in the treatment or prevention of ppar gamma-responsive diseases, including cancer |
| 12/19/2007 | EP1865951A1 Method for preventing cardiovascular diseases |
| 12/19/2007 | EP1865944A2 Amino acid-containing composition for preventing or remedying in the skeletal muscle of aged people |
| 12/19/2007 | EP1865938A2 Dosing regimes for trans-clomiphene |
| 12/19/2007 | EP1865928A1 Nanoparticulate biphosphonate compositions |
| 12/19/2007 | EP1865925A1 Buccal delivery system |
| 12/19/2007 | EP1865778A2 Methods for avoiding edema in the treatment of metabolic, inflammatory, and cardiovascular disorders |
| 12/19/2007 | EP1539713B1 Pyrimidine derivatives as modulators of chemokine receptor activity |
| 12/19/2007 | EP1503757B1 Tyrosine kinase inhibitors |
| 12/19/2007 | EP1490062B1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 12/19/2007 | EP1470122B1 Rho-kinase inhibitors |
| 12/19/2007 | EP1422224B1 Dithiazole compounds, matrix metalloprotease inhibitors and external preparations for the skin |
| 12/19/2007 | EP1406872B1 Dipeptidyl peptidase inhibitors for the treatment of diabetes |
| 12/19/2007 | EP1326856B1 Pyridine derivatives with ikb-kinase (ikk-beta) inhibiting activity |
| 12/19/2007 | EP1230369B1 Polypeptide hormone phosphatonin |
| 12/19/2007 | CN101090731A Use of bombesin/gastrin-releasing peptide antagonists for the treatment of inflammatory conditions, acute lung injury and bipolar disorder |
| 12/19/2007 | CN101088539A Externally applied Chinese medicine composition for treating rheumatic arthritis and calcification of posterior longitudinal ligament of vetebral body |
| 12/19/2007 | CN101088534A Medicine composition for treating bone necrosis and its prepn process |
| 12/19/2007 | CN101088527A Medicine composition for treating bone necrosis and its prepn process |
| 12/19/2007 | CN100355889C Design constructing method of gene engineering recombined dyad bone shape protein |
| 12/19/2007 | CN100355751C 2-substd. 4-heteroaryl-pyrimidines and their use in treatment of proliferative disorders |
| 12/19/2007 | CN100355748C Aromatic hydrazide kind compound and its use in preparation of immune inhibitor |
| 12/19/2007 | CN100355431C Humuli scandentis herbal wine for treating omarthritis |
| 12/19/2007 | CN100355417C Formulation of 'Duyiwei' with improved bioavailability and drug effect and preparation process thereof |
| 12/18/2007 | US7309800 Biphenylcarboxylic amide derivatives as p38 kinase inhibitors |